Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Sign Up to like & getrecommendations! Published in 2018 at "Clinics in liver disease"
DOI: 10.1016/j.cld.2017.08.012
Abstract: Treatment of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is focused on patients with NASH because they are at highest risk for progressive liver disease. Current first-line treatment consists of lifestyle modifications. Patients should lose… read more here.
Keywords: fatty liver; liver disease; treatment; nonalcoholic fatty ... See more keywords
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.
Sign Up to like & getrecommendations! Published in 2020 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2020.154203
Abstract: Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent disease and important unmet medical need. Current guidelines recommend, under specific restrictions, pioglitazone or vitamin E in patients with NASH and significant fibrosis, but the use… read more here.
Keywords: nonalcoholic steatohepatitis; current emerging; treatment; receptor ... See more keywords